Human herpesvirus 6 and multiple sclerosis: a one-year follow-up study

Area of Science:

• Neurovirology
• Immunology
• Infectious Diseases

Background:

• Relapsing-remitting multiple sclerosis (RRMS) is an autoimmune neurological condition.
• The role of viral infections, specifically Human Herpesvirus 6 (HHV-6) and Epstein-Barr Virus (EBV), in RRMS pathogenesis is under investigation.

Purpose of the Study:

• To investigate the potential association between HHV-6 and EBV and RRMS.
• To analyze the prevalence and active replication of HHV-6 and EBV in RRMS patients compared to healthy controls.

Main Methods:

• A one-year follow-up study involving 57 RRMS patients and 57 healthy blood donors (HBD).
• Quantitative real-time PCR was used to detect HHV-6 and EBV in peripheral blood mononuclear cells and serum.
• Clinical data, including age of onset and Expanded Disability Status Scale (EDSS) increase, were collected.

Main Results:

• No statistically significant difference in EBV was found between RRMS patients and HBD.
• HHV-6 prevalence was significantly higher in RRMS patients (80.7%) compared to HBD (29.8%).
• Active HHV-6 replication, specifically variant A, was observed in RRMS patients and appeared related to disease exacerbations, though clinical data did not reach statistical significance.

Conclusions:

• A higher frequency of active HHV-6A infection (reactivation or new infection) may lead to increased antigen exposure in RRMS patients.
• Active replication of HHV-6A seems specifically associated with exacerbations in a subset of RRMS patients.
• These findings suggest a potential role for HHV-6A in RRMS exacerbations.